Euro
USD
British Pound
NULL
Product Description
Bifeprunox shows positive effects in treating psychotic symptoms in schizophrenia. It is a third-generation antipsychotic agent which acts as a partial agonist at dopamine D2 receptors and is an efficacious agonist at serotonin 5-HT1A receptors. It shows little interaction at 5HT(2A/2C), muscarinic or histaminergic H1 receptors.
Bifeprunox shows positive effects in treating psychotic symptoms in schizophrenia. It is a third-generation antipsychotic agent which acts as a partial agonist at dopamine D2 receptors and is an efficacious agonist at serotonin 5-HT1A receptors. It shows little interaction at 5HT(2A/2C), muscarinic or histaminergic H1 receptors.
Biovision | B2921 | Bifeprunox DataSheet
Alternate Name/Synonyms: Bifeprunoxum; 7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-3H-1,3-benzoxazol-2-one; 7-[4-([1,1'-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3h)-benzoxazolone
Appearance: Solid
Formulation:
CAS Number: 350992-10-8
Structure Available?: True
Peptide sequence:
Salt Form: false
Molecular Formula: C₂₄H₂₃N₃O₂
Molecular Weight: 385.46
Cell-Permeable?: True
Purity: 97%
Solubilities: Soluble in DMSO in 0
Handling: Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.
Country of Origin: USA
Tag Line: A partial agonist of D2 receptor and efficacious agonist of 5-HT1A receptor
MDL Number:
PubChem CID: 208951
SMILES: C1CN(CCN1CC2=CC(=CC=C2)C3=CC=CC=C3)C4=CC=CC5=C4OC(=O)N5
InChi: InChI=1S/C24H23N3O2/c28-24-25-21-10-5-11-22(23(21)29-24)27-14-12-26(13-15-27)17-18-6-4-9-20(16-18)19-7-2-1-3-8-19/h1-11,16H,12-15,17H2,(H,25,28)
InChi Key: CYGODHVAJQTCBG-UHFFFAOYSA-N
